SHARE PRICE
Get to know the company overview of KOPRAN - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in KOPRAN
Current Price (Rs.) | 29.95 |
Face Value (Rs.) | 10 |
Book Value (Rs.) | 38.95 |
52 Week High (Rs.) | 46.10 (07-May-19) |
52 Week Low (Rs.) | 24.00 (10-Oct-19) |
Life Time high (Rs.) | 372.00 (01-Dec-94) |
Life Time low (Rs.) | 6.00 (20-Nov-08) |
Exchange Symbol | KOPRAN (NSE) |
Average Daily Movement [ADM] | 1.84 |
Average Volume [20 days](No. of shares) | 133549 |
Market Cap (Rs. in Cr) | 129.54 (Cr) |
1 Month Return (%) | 3.81 |
P/E Ratio (x) | 4.53 |
% of Promoter holding pledged | 0.00 |
SHARE PRICE CHART
We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.
We do not recommend daily/intraday minute hourly charts.
Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.
KOPRAN, NSE, INDIA
QUARTERLY RESULTS
Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | |
Quarterly | Quarterly | Quarterly | Quarterly | Quarterly | Quarterly | |
Source Of Info (AR = Annual Report, PR = Press Release) | ||||||
Net Sales/Income from operations | ||||||
Other Operating Income | ||||||
Total Income From Operations | ||||||
Increase/Decrease in Stocks | ||||||
Consumption of Raw Materials | ||||||
Purchase of Traded Goods | ||||||
Employees Cost | ||||||
Depreciation | ||||||
Other Expenses | ||||||
Total Expenditure | ||||||
Operating Profit | ||||||
Other Income | ||||||
P/L Before Int., Excpt. Items & Tax | ||||||
Interest | ||||||
P/L Before Exceptional Items & Tax | ||||||
Exceptional Item | ||||||
P/L Before Tax | ||||||
Tax | ||||||
P/L After Tax from Ordinary Activities | ||||||
PAT | ||||||
Net Profit/(Loss) For the Period | ||||||
Equity Share Capital | ||||||
Reserves | ||||||
EPS (Rs.) [After Extraordinary items] | ||||||
EPS (Rs.) [Before Extraordinary items] |
RATIO ANALYSIS
Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.
Name | Ratio | Good/Not Good | Description |
Current Ratio (x) | 2.28 | > 2 is Good, < 2 is Not Good |
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations. |
Quick Ratio (x) | 1.47 | > 1 is Good, < 1 is Not Good |
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets |
Dividend Yield (%) | 0.00 | > 1.5 is Good, < 1.5 is Not Good |
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share. |
Interest Coverage Ratio (x) | 5.49 | > 2 is Good, < 2 is Not Good (For Banks & NBFC this is not Valid) |
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses. |
Debt Equity Ratio (x) | 0.53 | < 2 is Good, > 2 is Not Good (For Banks & NBFC this is not Valid) |
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates. |
Return On Asset (%) | 6.90 | > 5% is Good, < 5% is Not Good |
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets |
Return On Equity (%) | 14.25 | > 18% is Good, < 18% is Not Good |
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE. |
For investors interested in KOPRAN find all important information on KOPRAN share price, peer comparison and analysis.
DIVIDEND
Get a glimpse into the dividend history-payout amount of KOPRAN, interim dividend and the latest dividend announcements by KOPRAN in the last 5 years.
# | Announcement Date | Ex-Date | Amount | Interim/Final |
---|---|---|---|---|
No Record Found. |
PROMOTER SHAREHOLDING
Look up all relevant information on shareholding pattern of KOPRAN, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.
Shareholding Pattern | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 |
Promoter and Promoter Group (%) | 43.78 | 43.78 | 43.78 | 43.78 | 43.78 |
Indian | 43.78 | 43.78 | 43.78 | 43.78 | 43.78 |
Foreign | NIL | NIL | NIL | NIL | NIL |
Institutions (%) | 2.56 | 2.94 | 2.90 | 2.69 | 2.84 |
FII | 0.00 | 0.00 | NIL | NIL | NIL |
DII | 2.56 | 2.94 | 2.90 | 2.69 | 2.84 |
NonInstitutions (%) | 53.66 | 53.28 | 53.33 | 53.53 | 53.38 |
Bodies Corporate | NIL | NIL | NIL | NIL | NIL |
Others | 53.66 | 53.28 | 53.33 | 53.53 | 53.38 |
Custodians | NIL | NIL | NIL | NIL | NIL |
Total no. of shares (cr.) | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 |
PUBLIC SHAREHOLDING
Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.
Persons holding securities more than 1% of total number of shares under category Public Shareholding. | Category | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Mar-17 |
Oricon Properties Pvt.Ltd. | Promoters | 13.78 | 13.78 | NIL | NIL | 13.78 |
Panorama Finvest Pvt.Ltd. | Promoters | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 |
Bodies Corporate | NonPromoters | 7.01 | 7.53 | NIL | 6.66 | 6.88 |
Sarvamangal Mercantile Co.Ltd. | Promoters | 6.71 | 6.71 | 6.71 | 6.71 | 6.71 |
Rajendra Somani | Promoters | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 |
Susheel Somani | Promoters | 2.02 | 2.02 | NIL | 2.02 | 2.02 |
Surendra Somani | Promoters | 1.16 | 1.16 | 1.16 | NIL | 1.16 |
Clearing Members | NonPromoters | NIL | 2.18 | NIL | NIL | 1.15 |
NRI â?? Repat | NonPromoters | 1.21 | 1.61 | NIL | NIL | NIL |
Foreign Individuals or NRI | NonPromoters | NIL | NIL | 1.68 | 1.62 | NIL |
COMPANY PROFILE
Study KOPRAN management, company profile, ownership, management, Board of Directors and Organization Structure of KOPRAN
COMPANY PROFILE OF KOPRAN, NSE, INDIA | |
---|---|
Date of Incorporation | 26-Apr-1958 |
Date of Listing | 01-Dec-1994 |
Management | |
Name | Designation |
Susheel G Somani | Chairman |
Arvind K Mehta | Director |
Siddhan Subramanian | Director |
Sunita Banerji | Director |
Vijay K Bhandari | Director |
Surendra Somani | Executive Vice Chairman |
Registered Office Address | |
"Parijat House",1076, Dr. E. Moses Road,Worli,, 400018, Mumbai, Maharashtra, India, | |
Website | |
http://www.kopran.com |
PEERS PRICE COMPARISION
# | Company Name | Open | High | Low | Last Price | Prv Price | Change | % Chng |
---|---|---|---|---|---|---|---|---|
1 | KOPRAN | 71.30 | 72.00 | 70.50 | 70.90 | 70.90 | 0 | 0.00 |
2 | VIMTA LABS | 128.40 | 130.40 | 128.40 | 129.00 | 129.00 | 0 | 0.00 |
3 | JB CHEMICALS | 280.25 | 283.15 | 275.00 | 275.90 | 275.90 | 0 | 0.00 |
4 | PFIZER | 1728.80 | 1730.05 | 1711.00 | 1717.15 | 1717.15 | 0 | 0.00 |
5 | BROOKS LAB | 107.00 | 112.50 | 107.00 | 108.80 | 108.80 | 0 | 0.00 |
6 | DISHMAN | 288.20 | 304.20 | 278.00 | 301.20 | 301.20 | 0 | 0.00 |
7 | MOREPEN LAB | 16.75 | 17.00 | 16.50 | 16.60 | 16.60 | 0 | 0.00 |
8 | SANOFI INDIA | 4208.95 | 4230.00 | 4200.00 | 4213.30 | 4213.30 | 0 | 0.00 |
9 | SUVEN | 222.05 | 230.40 | 218.10 | 221.15 | 221.15 | 0 | 0.00 |
10 | GLAXO PHARMA | 2464.00 | 2474.00 | 2436.30 | 2451.80 | 2451.80 | 0 | 0.00 |
11 | NATCO PHARMA | 995.95 | 995.95 | 983.00 | 986.70 | 986.70 | 0 | 0.00 |
12 | ALKEM LABORATORIES | 1841.00 | 1843.00 | 1821.00 | 1825.00 | 1825.00 | 0 | 0.00 |
13 | VENUS REMEDIES | 104.05 | 104.15 | 103.00 | 103.50 | 103.50 | 0 | 0.00 |
14 | JUBILANT | 657.60 | 662.85 | 641.60 | 643.70 | 643.70 | 0 | 0.00 |
15 | PIRAMAL ENTERPRISES | 2746.00 | 2774.90 | 2725.25 | 2761.50 | 2761.50 | 0 | 0.00 |
16 | BLISS GVS | 175.00 | 178.90 | 168.60 | 176.85 | 176.85 | 0 | 0.00 |
17 | SHILPA MEDICARE | 659.50 | 663.90 | 645.25 | 656.85 | 656.85 | 0 | 0.00 |
18 | PROCTER GAMBLE HEALTH | 1015.50 | 1072.00 | 1015.50 | 1064.30 | 1064.30 | 0 | 0.00 |
19 | MARKSANS PHARMA | 45.50 | 46.20 | 44.75 | 45.25 | 45.25 | 0 | 0.00 |
20 | SYNGENE | 495.10 | 503.65 | 491.00 | 493.95 | 493.95 | 0 | 0.00 |
21 | IPCA | 500.00 | 503.45 | 493.00 | 495.55 | 495.55 | 0 | 0.00 |
22 | OPTO CIRCUITS | 6.95 | 7.00 | 6.90 | 6.95 | 6.95 | 0 | 0.00 |
23 | ALEMBIC PHARMA | 500.00 | 501.70 | 497.00 | 500.30 | 500.30 | 0 | 0.00 |
24 | CAPLIN POINT | 700.40 | 707.50 | 690.20 | 697.90 | 697.90 | 0 | 0.00 |
25 | RPG LIFE | 387.55 | 405.00 | 387.55 | 396.80 | 396.80 | 0 | 0.00 |
26 | SPARC | 370.40 | 374.80 | 365.50 | 367.85 | 367.85 | 0 | 0.00 |
27 | FDC | 183.10 | 188.10 | 183.10 | 186.75 | 186.75 | 0 | 0.00 |
28 | NECTAR LIFESCIENCES | 27.65 | 27.65 | 26.95 | 27.20 | 27.20 | 0 | 0.00 |